An Interventional, Multicenter, Single Arm, Phase I/IIA Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-EB on Epidermolysis Bullosa (EB)

Project: Research project

Description

An Interventional, Multicenter, Single Arm, Phase I/IIA Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-EB on Epidermolysis Bullosa (EB)
StatusActive
Effective start/end date7/1/196/30/24

Funding

  • RHEACELL GMBH & CO KG

Fingerprint

Epidermolysis Bullosa
Clinical Trials, Phase I
Safety